BioStorage Technology Inc., an Indianapolis-based provider of biomaterial storage, has received an undisclosed amount of VC funding from Spring Mill Venture Partners. The company previously had raised just over $5 million from Radius Ventures and Twilight Venture Partners. www.biostoragetech.com
AsicAhead NV, a Hasselt, Belgium-based provider of mobile RF integrated circuits for the WiMAX market, has raised $10 million in Series B funding. Capital-E led the deal, and was joined by return backers LRM, SHF and Allegro. www.AsicAhead.com
Corrigo Inc., a Wilsonville, Ore.-based provider of on-demand service management solutions, has acquired Aligo Inc., a San Francisco
Quantum, a Houston-based private equity firm focused on the energy sector, has closed its fourth fund with $1.32 billion in capital commitments. Champlain Advisors served as placement agent. www.quantumep.com
RF Nano Corp., an Orange County, Calif.-based developer of radio frequency devices, has raised $1.5 million in Series A funding from Okapi Ventures of Laguna Beach. The company is commercializing technology developed at UC Irvine that is designed to change the way real world signals are manipulated and processed.
Tamara Elias has joined Essex Woodlands Health Ventures as a New York-based principal. She previously focused on the pharmaceuticals market at McKinsey & Co., and received her M.D. from Johns Hopkins. www.ewhv.com
Frantic Films, a Winnipeg, Canada-based visual effects, film and television production company, has raised Cnd$5 million in VC funding from Priveq Capital Funds. The proceeds will be used to fund the growth of all Frantic's divisions through acquisitions and investment in current operations.
Monomoy Capital Partners has closed its inaugural turnaround fund with $280 million in capital commitments. Limited partners include Drum Capital, Bear Stearns Asset Management, Horizon 21 (formerly Swiss Re), Oppenheimer & Co., St. Paul-Travelers, and Morgan Creek Capital. MVision Private Equity Advisors served as placement agent. www.mcpfunds.com
Excellere Partners, a Denver-based private equity firm that is targeting $200 million for its inaugural fund, has received a $25 million commitment from LACERA. The firm is run by former KRG Capital Partners partners David Kessenich and Robert Martin. http://www.lacera.com/
Sequoia Pharmaceuticals Inc., a Gaithersburg, Md.-based drug developer focused on the treatment of drug-resistant HIV infections, has raised $35 million in Series C funding. The Wellcome Trust led the deal, and was joined by fellow existing shareholders Healthcare Venture, Sofinnova Partners and Aberdare Ventures. New backer MedImmune Ventures also participated. http://www.sequoiapharma.com/